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Optimization of iron analyses using ESI-MS: Detection of iron oxide in pharmaceuticals 
Dendi Susanto 
Detection of iron oxide in pharmaceutical formulations using electrospray ionization 
mass spectrometry (ESI-MS) following iron complexation with 1,10-phenanthroline 
(Phen), l-(2-pyridylazo)-2-naphthol (PAN), and 4-(2-pyridylazo)resorcinol (PAR) was 
evaluated. Complexation of Fem with PAR was found to produce a distinctive and 
sensitive mass spectral signal when compared to the other ligands. In selected ion 
monitoring (SIM) scan mode, the signal at m/z 484 arising from the iron-PAR complex 
gave a limit of detection of 2 uM for total iron using a triple-quadrupole mass 
spectrometer. The range of the calibration curve was determined to be 2 - 43 uM total 
iron. Trace iron interferences from the labware and instrumentation were minimized 
considerably by selection of an optimized cleaning protocol and instrument replumbing 
using PEEK® tubing. Figures of merit for total iron analysis (specificity, linearity, 
precision and accuracy, robustness, and stability) were within the acceptance criteria of 
the US FDA validation guidelines for the pharmaceutical industry. Recovery of 93% of 
the added iron indicated a satisfactory extraction procedure for tablets containing iron 
oxide pigment. There was no statistical difference between the results obtained by ESI-
MS and a conventional method such as inductively coupled plasma-optical emission 
spectroscopy (ICP-OES). The proposed ESI-MS method was found to be specific, 
sensitive, and relatively inexpensive since it can be performed on a mass spectrometer 
- iii -
equipped with an ESI source, which is standard instrumentation in the pharmaceutical 
industry. Thus, the method validated here provides an alternative to laboratories that do 
not have specialized and dedicated instrumentation for elemental analysis. 
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Chapter 1 General Introduction 
The following thesis describes the determination of total iron in pharmaceutical 
products containing iron oxide pigment. The suitability of ligands for quantitative 
analysis was investigated. Method validation figures of merit for quantitative analysis are 
discussed in Chapter 2. The behaviour of the metal ion complexes noted during method 
development is described in Chapter 3. Finally, concluding remarks and suggestions for 
future work are presented in Chapter 4. 
The scope of this thesis is to determine the total iron present in pharmaceutical 
products using a mass spectrometer equipped with an electrospray (ESI) source. Since 
this method will be adopted for pharmaceutical use, the method validation figures of 
merit are based on the regulatory guidelines, especially those of the United States Food 
and Drug Administration (US FDA). Investigations of other techniques will not be 
discussed in this thesis. 
Colors from synthetic pigments are used in pharmaceutical finished products for 
identification, appearance, as well as product stability. Only a handful of pigments are 
approved by the regulatory agencies worldwide, including the US FDA. The approved 
pigments are indigo carmine, brilliant blue, sunset yellow, titanium dioxide, and iron 
oxide [1]. Synthetic pigment containing iron oxide, FeiC^ which represents one of the 
excipients in pharmaceutical formulations, not only gives an appealing color to the final 
drug product, but it also protects the active pharmaceutical ingredients (APIs) from 
degradation upon exposure to light [2]. Iron oxide is added to drug products as a blend in 
the granulation or as a film coating to a core tablet [3]. 
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The FDA requires that synthetic iron oxide pigment is not more than 3% w/w of 
the total tablet weight and the pigment must not contain more than 55% Fe203. Currently, 
specification of the iron oxide content in a tablet is not part of the release requirement for 
pharmaceuticals manufacturers. However, it is part of the batch record, which clearly 
identifies all formulation ingredients. The pigment is accounted for in a tablet 
formulation by the percent weight composition of overall tablet weight. The current 
release requirements of the drug product consist only of an identification test to confirm 
the existence of the pigment in the tablet [4]. This will change in a few years as the 
United States Pharmacopeia, the pharmaceutical standard-setting organization in the US, 
proposes new standards for pharmaceutical manufacturers to report metal content in their 
products, as recently described in Chemical and Engineering News [5]. 
Common methods for elemental analysis such as colorimetry involve 
complexation of metal ions with appropriate ligands to form complexes that exhibit 
strong UV-Vis absorbance. However, this procedure can suffer from spectral interference 
when more than one metal species is present, and therefore mathematical derivatisation 
techniques are used to overcome this problem [6, 7]. 
HPLC-based methods also require metal ions to be complexed if reversed-phase 
chromatography is to be used [8]. This approach requires analytical method development 
to separate the metal ions of interest. In addition, HPLC can offer metal-ion separation 
without the need for complexation. This approach, ion chromatography, requires a special 
HPLC instrument made of metal-free components to achieve the separation goals without 
interference [9]. 
Atomic absorption spectrophotometric (AAS) methods, with either flame or 
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graphite furnace atomization, offer direct analysis of metal content. One metal is 
generally analyzed at the time, so throughput limitation results in lengthy sample 
processing that is time consuming and labour intensive [10, 11]. 
Inductively coupled plasma (ICP) analysis coupled with mass spectrometry (MS) 
or optical emission spectroscopy (OES) is the ideal choice for elemental analysis. These 
methods are capable of running multi-element analyses simultaneously, thereby giving a 
high throughput advantage over other techniques [12, 13]. The disadvantages of ICP 
methods are the high overhead cost of operating the instrumentation as well as the need 
for skilled operators, especially in the case of ICP-MS. These drawbacks deter many 
laboratories from purchasing instrumentation dedicated to elemental analyses. 
Matrix assisted laser desorption ionization - time of flight mass spectrometry 
(MALDI-TOF MS) methods make use of ligands that complex the metal ion of interest as 
a matrix in the ionization process. The sample exists as a solid and the laser beam creates 
ionization. The resulting mass spectrum confirms formation of the complex ion of the 
desired metal ions with ligands [14]. For example, Matsumoto et al. [14] have shown that 
iron oxides can be detected using MALDI-TOF MS when l-(2-pyridylazo)-2-naphthol 
(PAN), 4-(2-pyridylazo) resorcinol (PAR) or 1,10-phenanthroline (Phen) are employed as 
MALDI matrices to complex the iron. MALDI-TOF MS is good for qualitative and 
screening purposes. However, it lacks the quantitative power to determine the amounts of 
the metal ions in the samples [15]. 
Electrospray ionization mass spectrometry (ESI-MS), on the other hand, is used in 
many laboratories for multiple types of analyses, including metal ion analysis. Using this 
approach, the metals also need to be complexed with appropriate ligands due to 
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limitations of ESI-MS detection. Nonetheless, ESI-MS provides an alternative for the 
qualitative and quantitative analyses of metal-ligand complexes [16, 17]. 
ESI-MS was developed as a useful and versatile tool following the work of Fenn 
[18] in the early 1980s. In this process, a solution is passed through a small capillary tube 
which produces charged spray droplets on applying a high electric potential. As the 
solvent is evaporated, the charge density becomes higher until coulombic repulsion takes 
place breaking the bigger droplets into smaller ones. This process continues until the 
analyte ions are essentially desolvated and accelerated toward the mass analyzer. The 
advantage of ESI is the ability to elucidate the structure of molecules and their properties, 
hence its use in many applications. 
Since quantitation by MALDI-TOF MS is limited as previously mentioned, ESI-
MS analysis of iron was explored here. This thesis will demonstrate the capability of ESI-
MS for total iron analysis from pharmaceutical tablets containing synthetic iron oxide 
pigments. Method optimization and validation, as well as metal ion behaviour are 
outlined in the following two chapters. 
To confirm the validity of the method developed, a comparative study was 
performed by ICP-OES. While ESI-MS is unlikely to replace elemental analysis by ICP-
OES, ICP-MS or AAS, it can provide an alternative when dedicated instruments are not 
available. The ESI-MS method developed here not only offers advantages in selectivity 
over common techniques such as colorimetry, it also offers simplicity. Extensive analyte 
separation by chromatographic methods is not required because of the mass resolution of 
the mass spectrometer. 
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Chapter 2 Development and validation of a quantitative method for 
iron in pharmaceutical products 
2.1 Introduction 
In this chapter, ESI-MS method validation figures of merit for quantitative 
analysis of total iron in pharmaceutical tablets are discussed. Using ligands from the 
MALDI-TOF MS work of Matsumoto et al. [14], evaluation of ESI-MS for total iron 
analysis was carried out. Figures of merit were established using the best ligand. Tablets 
containing iron oxide pigment were measured for total iron using the validated method. 




The following chemicals were obtained from Sigma-Aldrich (St. Louis, MO, 
USA): 1,10-phenanthroline monohydrate, l-(2-pyridylazo)-2-naphthol (PAN, anhydrous 
free base, indicator grade 98%), 4-(2-pyridylazo) resorcinol (PAR, anhydrous free base, 
indicator grade 98%), hydroxylamine HC1 (ACS Reagent, 99%), NH4OH (98% certified) 
and L-ascorbic acid (99% certified). Formic acid (mass spectrometry grade, puriss >98%) 
was obtained from the Fluka, division of Sigma-Aldrich. Thermo Fisher Scientific (NY, 
USA) was the supplier of ammonium formate (HPLC grade, 99%), and sodium 
hydroxide (ION, certified reagent), methanol and acetonitrile (HPLC grade). 
Concentrated HC1 solution (plasma pure grade) was from SCP Science (Baie d'Urfe, 
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Quebec, Canada). The iron standard for atomic absorption spectroscopy (1000 ppm) was 
obtained from Ricca Chemical Co (Arlington, TX, USA). Pharmaceutical film-coated 
and compressed tablets containing iron oxide pigments were available from Merck Frosst 
Canada Ltd, a division of Merck & Co. (NJ, USA). Synthetic pigment containing iron 
oxide for qualitative evaluation was obtained from Elementis Pigment (Fairview Hill, IL, 
USA). Ultrapure double-deionized water was obtained from a Milli-Q water purification 
system (Bedford, MA, USA). PEEK® tubing was obtained from VICI Valco Instruments 
(Houston, TX, USA). 
2.2.2 Instrumentation 
ESI-MS analysis was carried out initially using a LCQ Deca® ion trap mass 
spectrometer fitted with an electrospray ionization source (ThermoQuest Finnigan, San 
Jose, CA, USA). To enhance sensitivity of detection, a triple quadrupole mass 
spectrometer (TSQ7000) fitted with an electrospray ionization source (ThermoQuest 
Finnigan, San Jose, CA, USA) was additionally used. Data were acquired and processed 
with Xcalibur 2.0 software. The mass spectrometer was mass calibrated using standard 
calibration solutions, Ultramark 1621, MRPA (peptide Met-Arg-Phe-Ala) (Alfa Aesar, 
Ward Hill, MA, USA) and caffeine (Sigma-Aldrich, St. Louis, MO, USA). The 
instruments were operated in positive-ion mode and instrumental parameters were 
optimized using the Autotune® feature of Xcalibur for solutions containing dissolved iron 
and ligand at the expected mass-to-charge ratio of the complex molecules. Samples (50 
uL) in 50% acetonitrile/ 0.1% formic acid (v/v) were analyzed by direct-flow injection 
from an 1100 HPLC system (Agilent Technologies, Palo Alto, CA, USA) at a flow rate 
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of 1 mL/min and split at 120 uL/min to the ESI source. Table 2.1 summarizes the optimal 
source parameters for free ligand analysis using the ion trap mass spectrometer, and 
Table 2.2 summarizes the optimal conditions for the quantitation of total PAR-bound iron 
using the triple quadrupole mass spectrometer. Mass spectral scans were recorded 
between m/z 100 and 1000 at a scan time of 1 min. 
Table 2.1: ESI source parameters for free ligand detection using the LCQ DECA ion trap 
mass spectrometer" 
Parameters 
ESI source voltage (kV) 
Heated capillary voltage (V) 
Tube lens offset (V) 
Heated Capillary Temp (°C) 
Nitrogen sheath gas flow rate b 
Nitrogen aux. gas flow rate 






















 Operated in positive-ion mode with 8 uM PAN, 10 ^ M PAR dissolved in 50% aq 
methanol/0.1% formic acid (pH 2.5) and 25 uM of phen in 50% aq methanol/20 mM ammonium 
formate pH 3.5. Sample solutions were infused using a 250-uL Hamilton syringe at a flow rate of 
10 uL/min. b Arbitrary units 
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Table 2.2: ESI source parameters for total iron quantitation complexed by PAR using the 
TSQ7000 triple quadrupole mass spectrometer" 
Parameters 
ESI source voltage (kV) 
Capillary voltage (V) 
Capillary offset voltage (V) 
Lens 1-1 voltage (V) 
Heated Capillary Temp (°C) 
Nitrogen sheath gas flow rate 










 Operated in positive-ion mode with 50 uL solution containing 43 uM Fe standard and 233 uM 
PAR in 50% aq acetonitrile. The mobile phase was 50% aq acetonitrile/0.1% formic acid (pH 2.5) 
delivered from an HPLC with a flow rate of 120 uL/min. b Arbitrary units 
Absorbance readings in the colorimetric analysis of iron were measured on a 
Model 8453 diode-array spectrophotometer (Agilent Technologies, Palo Alto, CA, USA), 
and solution pH values were monitored using a Thermo Orion 920A+ pH meter with a 
glass-filled electrode (Thermo Electron, San Jose, CA, USA). 
ICP-OES analyses were carried out using an iCap 6500 ICP-OES (Thermo Electron, 
San Jose, CA, USA) with argon gas as a nebulizer. The sample flush time was set at 30 s 
and the plasma was generated using a RF power of 1150 W. The nebulizer gas flow was 
set at 0.7 L/min and the auxiliary gas flow at 0.5 L/min. The 259.9-nm emission line of 
iron, which corresponds to its strongest emission, was used for its detection and 
quantitation. This emission line is selected from the internal database in the iCap when 
iron is analyzed. Triplicate measurements at 259.9 nm were recorded for each sample and 
average values are reported (Section 2.4.5). 
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2.2.3 Labware and cleaning protocols 
To minimize interference from trace iron found in materials, specialized labware 
was used throughout the experiments. Polycarbonate-based volumetric flasks from 
Nalgene (Thermo Fisher Scientific, NY, USA) were employed in sample and calibrant 
preparation. The flasks were subjected to the standard company (Merck Frosst) pre-wash 
cleaning procedure for labware prior to use. The pre-wash consisted of the following 
steps: 
Labware was soaked overnight with absolute ethanol, and rinsed with tap water. 
- Labware was loaded into the washer (Labconco, Missouri, USA) with the following 
cycles: 
o Wash cycle with soap containing tetrasodium EDTA (Glass Klenz, Steris, St. 
Louis, Mo, USA) at room temperature (30 min). 
o Rinse cycle with double deionized Milli-Q water at room temperature (30 
min). 
o Wash cycle with soap containing 25% w/w citric acid (Calgon Vestal Labs, 
Bramalea, Ont, Canada) at room temperature (30 min). 
o Rinse cycle with double deionized Milli-Q water at room temperature (30min) 
o Labware was then loaded into oven (70°C for 1 h) or until dry. 
After the company wash, volumetric flasks were additionally rinsed 3x with 10% HC1 
(plasma pure grade), and rinsed 3x with Milli-Q water. 
2.2.4 Calibration curve preparation 
Calibration and quality-control samples were prepared by diluting the appropriate 
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volume of intermediate standard solutions into 50-mL Nalgene volumetric flasks as 
summarized in Table 2.3. Intermediate solutions were prepared from the standard Fe 
stock solution (Ricca Chemical Co, TX, USA) by diluting the volume indicated in Table 2.3 
into a 100-mL volumetric flask and adjusting to the mark with Milli-Q water. With a 
graduated cylinder, 25 mL of 465 uM PAR, prepared freshly in acetonitrile, was added to 
each flask, and adjusted to the mark with Milli-Q water. A matrix blank was prepared in 
the same manner as the calibration samples by replacing the intermediate standard 
solution with Milli-Q water. Uniform mixing was ensured by inverting the volumetric 
flask 3 times and the solutions were left standing overnight at ambient laboratory 
conditions before assay. 








(20 ppm Fe) 
Intermediate B 
(1 ppm Fe) 
Concentration 






2 mL of stock (1000 ppm Fe) in 100 mL of Milli-Q H20 












































Stock solution, 1000 ppm Fe in 3% aq HC1 (Ricca Chemical Co, TX, USA) 
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2.2.5 Tablet extraction procedure 
Ten intact tablets per flask, each tablet weighing approximately 100 mg, were 
added into 50-mL Nalgene volumetric flask. Into each flask, 2mL of water was added to 
help disintegrate the tablets, and after complete disintegration, 20 mL of concentrated 
HC1 (Plasma pure grade) was added. The flasks were placed in an ultrasonic bath for 30 
min and shaken vigorously at 15-min interval for approximately 1 min to ensure 
complete extraction. At end of sonication, Milli-Q water was added to below the mark, 
and the solutions were left to cool at room temperature before adjusting to the mark with 
Milli-Q water. A 13-mL portion was transferred into a 15-mL Eppendorf tube for 
centrifugation at 3500 rpm for 15 min. With a glass volumetric pipette, 10 mL of the 
supernatant was transferred into a clean 50-mL volumetric flask and adjusted to the mark 
with Milli-Q water. 
With a clean volumetric pipette, 10 mL of the diluted solution was transferred into 
a clean beaker, and the pH was adjusted to ~ 1.8 with the dropwise addition of 15 M 
aqueous NH4OH and then the dropwise addition of 1 M NH4OH to prevent overshooting 
the desired pH of- 2.3. This solution was transferred quantitatively to a clean 50-mL 
volumetric flask, and 25 mL of 465 uM PAR in acetonitrile was added from a graduated 
cylinder. The beaker was rinsed a few times with Milli-Q water, the rinsings were added 
to the volumetric flask, and the solution was adjusted to the mark with Milli-Q water. The 
sample was left standing overnight at ambient laboratory conditions before assay. 
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2.3 Qualitative evaluation of ligands for ESI-MS analysis of iron 
To enable the detection of the iron in the samples, ligands were examined based 
on the study by Matsumoto et al. [14]. The absorption spectra of the free ligands 
evaluated in this thesis are shown in Figure 2.1, and their structures and properties are 
summarized in Table 2.4. 
Solubilization of iron oxide requires a strong acid such as concentrated HC1 [19]. 
In this evaluation, pigment containing iron oxide was solubilized in 500 ppm aq HC1. A 
working pigment solution was prepared by diluting 2 mL of the stock pigment solution 
into a 100-mL volumetric flask, and adjusting to the mark with Milli-Q water. 
1.4 -i 
190 290 390 490 
Wavelength (nm) 
590 
Figure 2.1: UV-Vis absorption spectra of free ligands. Spectra were recorded in a 1-cm 
cuvette. Ligands were dissolved in methanol to give 50 \iM Phen, 16 |nM PAN, and 19 ^M PAR 
at ambient temperature. 
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Table 2.4: Structures of free ligands and their properties relevant to iron chelation a'b 
1,10-phenanthroline 
(Phen) [20, 21] 
H 
Mr 180.21 u 
Bidentate ligand 
pK 4.96 
FenL3complex (Mr 298 u) 
-^max 510 nm 
esio 1.12x10* NT'cm"1 
1 -(2-pyridylazo)-2-naphthol 
(PAN) [21, 22] 
A r 
UU 
Mr 249.27 u 
Bi- or tridentate ligand 
pK, 2.3, pK212.3 
FemL2 complex (Mr 552 u) 
-^max 765 nm 
e765 2.7xl04 M"'cm"' 
4-(2-pyridylazo)resorcinol 
(PAR) [21, 23] 
Mr 215.21 u 
Bi- or tridentate ligand 
pK,2.7,pK25.5(para-OH), 
pK312.3 
FenIL2 complex (Mr 484 u) 
•^max 500 nm 
e50o5.60xl04 M"'cm"' 
"Coordinating atoms are shown in red. b Fully protonated forms of the ligands are shown. 
Solvents were 0.05 M aq sulphuric acid (pH <1) for Phen [20], dichloromethane for PAN [22], 
0.01 N aq HC1 (pH adjusted to 8.8-10.3) for PAR [23], other data were taken from [21]. 
2.3.1 1,10-Phenanthroline (Phen) 
Fe3+ is reduced to Fe2+ by NH2OH according to equation 2.1. Three mole 
equivalents of Phen complex with each mole equivalent of Fe2+ to form [Fe"(Phen)3]2+ 
(eq. 2.2). The complex is stable between pH 3 and 9 [24]. 
Fe3+ + NH2OH + OH- = ^ = ^ Fe2+ + V2 N2 + 2 H20 2.1 
Fe2+ + 3 Phen ^ = ^ [Fe"(Phen)3]2+ 2.2 
A 6-mL aliquot of 10 ppm pigment in ~ 0.24 N HC1 and 1 mL of 1.44 mM 
NH2OH in Milli-Q water, and 20 mL of 125 uM Phen in 100% methanol were diluted to 
50 mL with 20 mM ammonium formate (pH 3.5) to yield a solution that contains - 7 . 5 
- 1 3 -
uM Fe and 50 uM Phen. ESI mass spectra were recorded following direct flow 
injection of the samples from the HPLC to the ion trap MS. The ESI mass spectrum 
exhibits the MH+ ion of free Phen at m/z 181 as the base peak (Figure 2.2). The medium 
intensity peak at m/z 208 corresponds to the doubly charged ion of the [Fen(Phen)2] + 
complex as indicated by the half integer spacing between the isotopic peaks (Figure 2.2A, 
inset). Evidence for the formation of the [ClFen(Phen)2]+ complex ion at m/z 451 is 
obtained from the isotopic pattern (3:1, M:M+2) of the chloride ion apparent in the zoom 
scan shown in Figure 2.2B. 
Although the [Fen(Phen)3]2+ complex was not observed at m/z 298 in the mass 
spectrum, the UV-Vis absorption spectrum (Figure 2.3) of the 7.5 uM Fem / 50 uM Phen 
solution described above exhibits a visible maximum at 510 nm with an absorbance of 
0.1 AU confirming the complexation of all the iron as [Fe"(Phen)3]2+. Formation of 
[Fen(Phen)3]2+ is widely used in the spectrophotometric determination of iron [20, 24, 25]. 
The complex is characterized by its red-orange color and distinctive visible absorption 
maximum at 510 nm as shown in Figure 2.3.The number of ion counts in the ESI mass 
spectrum was on the order of 108 for the base peak (MH+ ion of Phen) indicating efficient 
ionization of free Phen under the conditions used (50% aq methanol/20 mM ammonium 
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Figure 2.2: ESI mass spectrum of solution containing 7.5 uM pigment-derived iron and 50 
uM Phen. The iron solution was prepared by mixing 6 mL of 10 ppm pigment in ~ 0.24 N aq 
HC1, 1 mL of 1.44 mM NH2OH in Milli-Q water, 20 mL of 125 uM Phen in 100% methanol, and 
diluting to 50 mL with 20 mM ammonium formate pH 3.5. A 50-uL sample aliquot was directly 
injected with the mobile phase (50% aq methanol/20 mM ammonium formate pH 3.5) at a flow 
rate of 1 mL/min and split at 120 uL/min to the ion source. The heated capillary temperature was 
set at 350°C. Insets (A) and (B) are expanded views at the m/z values of the ions of interest. The 
mass spectrum was obtained with a 1-min scan time, and each scan was set at 50 ms. 
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Figure 2.3: UV-Vis absorption spectrum of [Fen(Phen)3]2+. (A) lx spectrum. (B) 40x spectrum. 
Absorbance readings were taken in a 1-cm cuvette. The iron solution was prepared by mixing 6 
mL of 10 ppm pigment in ~ 0.24 N aq HC1, 1 mL of 1.44 mM NH2OH in Milli-Q water, 20 mL 
of 125 uM Phen in 100% methanol, and diluting to 50 mL with 20 mM ammonium formate pH 
3.5. 
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Since the expected tris complex, [Fen(Phen)3]2+, was not detected as a doubly 
charged ion at m/z 298, it was suspected that this ion picked up two chloride ions to form 
a neutral species that would not be detected by ESI-MS. To prevent the formation of the 
putative neutral complex Cl2[Fe1I(Phen)3], attempts were made to dissolve iron oxide 
pigment in alternate acids such as concentrated HNO3, H2SO4 or H3PO4. These were not 
successful due to the limited solubility of the oxide. Changing the mobile phase from 
ammonium formate (pH 3.5) to formic acid (pH 2.5) also did not lead to detection of the 
tris complex by ESI-MS under the conditions used in this experiment. Keki et al. have 
established a simple method for estimating activation energies for a collision-induced 
dissociation of [Fe (Phen^] and related complexes by ESI-MS. The complexes were 
prepared in water [26], which would have been impossible here due to insolubility of iron 
oxide in water. To release iron from the iron oxide, concentrated HC1 acid is required. 
To further investigate the failure to detect the [Fen(Phen)3]2+ complex by ESI-MS, 
FeSC>4, a salt that is highly soluble in water, was used to prepare an Fe solution. The 
iron was at the same concentration used previously except that hydroxylamine reduction 
(eq. 2.1) was not required in this case. A [Fen(Phen)3]2+ solution was prepared in water 
and approximately 10 uL of 1 M HC1 was added to one aliquot. A peak at m/z 298 was 
expected in the mass spectrum of the solution without HC1 but not in the solution with 
HC1. Figure 2.4 reveals that the mass spectrum did not exhibit a peak at m/z 298 in the 
absence of added HC1. Another reason for the failure to detect the tris complex may be 
thermal degradation of the complex in the heated capillary. On lowering the capillary 
temperature from 350°C to 150°C, the peak at m/z 298 became the base peak (Figure 
2.5C). With the heated capillary temperature set at 150°C, the solution containing HC1 
- 1 7 -
was injected and the base peak was also at m/z 298 (Figure 2.5D). This suggests that the 
[Fen(Phen)3]2+ complex is thermally labile in an ESI source equipped with a heated 
capillary above 150°C. But with heated capillary temperature set at 150°C, the mass 
spectrum of the acidified solution is noisy and shows many cluster ions due to the 
ineffecient desolvation (Figure 2.5D). Thus, other iron ligands were examined for their 
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Figure 2.4: ESI mass spectrum of an aqueous solution of 7 uM FeS04 with 50 uM Phen in 
40% aq methanol/20mM ammonium formate pH 3.5. The iron solution was prepared by 
mixing 6 mL of 60 uM FeS04 in Milli-Q water with 20 mL of 125 uM Phen in 100% methanol, 
and diluting to 50 mL with 20 mM ammonium formate pH 3.5. A 50-uL sample aliquot was 
directly injected with the mobile phase (50% aq methanol/20 mM ammonium formate pH 3.5) at 
a flow rate of 1 mL/min and split at 120 uL/min to ion source. The heated capillary temperature 
was set at 350°C. The mass spectrum was obtained with a 1-min scan time, and each scan was set 
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Figure 2.5: ESI mass spectra of aqueous solutions of 7 uM FeS04 and 50 uM Phen in 40% 
aq methanol/20mM ammonium formate pH 3.5 (A-C) without HC1 (D) with 10 mM HC1. 
The iron solution was prepared by mixing 6 mL of 60 uM FeS04 in Milli-Q water with 20 mL of 
125 uM Phen in 100% methanol, and diluting to 50 mL with 20 mM ammonium formate pH 3.5. 
A 50-uL sample aliquot was directly injected with the mobile phase (50% aq methanol/20 mM 
ammonium formate pH 3.5) at a flow rate of 1 mL/min and split at 120 uL/min to ion source. The 
heated capillary temperature was set at 350°C. The mass spectrum was obtained with a 1-min 
scan time, and each scan was set at 50 ms. 
2.3.2 l-(2-pyridylazo)-2-naphthol(PAN) 
An alternate ligand to Phen was evaluated because of difficulties in detecting the 
[Fen(Phen)3]2+ complex by ESI-MS. Reactions using PAN were carried out at low pH (< 
2.5) and high pH (> 10) close to the pKa values of PAN's coordinating groups (Table 2.4). 
Two 50-mL solutions containing 7.5 uM FeHI and 16 uM PAN (final concentrations) 
were prepared from 6 mL of 10 ppm pigment solution in ~ 0.24 N aq HC1. After 
adjusting the pH to 11 and 2.4 with dropwise addition of 1 N NaOH, 20 mL of 40 uM 
- 1 9 -
PAN (final concentration) in 100% methanol was added, and the volume was adjusted to 
50 mL with Milli-Q water. The ESI mass spectra are shown in Figure 2.6. The MH+ ion 
of free PAN at m/z 250 is the base peak in all spectra except that recorded at pH 2.4 in 
the presence of pigment-derived iron (Figure 2.6D). In this spectrum, a single high 
intensity peak at m/z 552 is assigned to the [Fem(PAN)2]+ complex. However, at both 
pHs, there is interference at m/z 552 (Figure 2.6A and 2.6C), suggesting the presence of 
iron in the reagents. In contrast, at pH 11 there is little difference between the spectra of 
the PAN solutions with and without iron pigment (Figure 2.6B and 2.6A). The use of this 
ligand was abandoned, and another iron ligand was explored. 
2.3.3 4-(2-pyridylazo)resorcinol (PAR) 
A third ligand was examined to determine if the iron content can be reliably 
quantitated by ESI-MS. Evaluation with PAR was also carried out at low pH (< 2.5) and 
high pH (> 10) close to the pKa values of PAR's coordinating groups (Table 2.4). Two 
50-mL solutions containing 7.5 uM FeIU and 19 uM PAR (final concentrations) were 
prepared by mixing 6 mL of 10 ppm pigment in ~ 0.24 N aq HC1. After adjusting the pH 
to 11 and 2.4 with dropwise addition of 1 N NaOH, 20 mL of 47 uM PAR (final 
concentration) in 100% methanol was added and the volume was adjusted to 50 mL with 
Milli-Q water. The ESI mass spectra shown in Figure 2.7 reveal that at high pH the mass 
spectra are very noisy but the [Fem(PAR)2]+ ion is visible above the noise at m/z 484 
(Figure 2.7B). At low pH, the mass spectra exhibit little noise, and the intensity of the M+ 
ion of [Fem(PAR)2]+ is very high relative to the background (Figure 2.7D). Upon binding 
to Fem, the ortho hydroxyl group of the resorcinol ring (Table 2.4) is deprotonated so that 
- 2 0 -
each ligand carries a single negative charge giving rise to an overall +1 charge for the 
[FeIH(PAR)2]+ complex ion. The free PAR ligand is poorly ionized compared to the 
complex ion under the experimental conditions used as evidenced by the low intensity of 
its MH+ ion at m/z 216 (Figure 2.7D). This is advantageous because excess free ligand 
will not suppress the signal of the complex ion at m/z 484. Since the PAR complex of 
iron at low pH also produces a more intense MH ion relative to the PAN complex 
(Figure 2.6D vs 2.7D), PAR was selected as a suitable ligand for further ESI-MS work. 
100-
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Figure 2.6: ESI mass spectra of solutions containing 7.5 uM pigment-derived iron and 16 
uM PAN in 40% aq methanol. The iron solution was prepared by mixing 6 mL of 10 ppm 
pigment in ~ 0.24 N aq HC1 with 20 mL of 40 uM PAN in 100% methanol, and diluting to 50 mL 
with Milli-Q water after pH adjustment. A 50-uL sample aliquot was directly injected with the 
mobile phase (50% aq methanol/0.1% formic acid) at a flow rate of 1 mL/min and split at 120 
uL/min to ion source. The heated capillary temperature was set at 350°C. The mass spectrum was 
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Figure 2.7: ESI mass spectra of solutions containing 7.5 uM pigment-derived iron and 19 
uM PAR in 40% aq methanol. The iron solution was prepared by mixing 6 mL of 10 ppm 
pigment in ~ 0.24 N aq HC1 with 20 mL of 47 uM PAR in 100% methanol, and diluting to 50 mL 
with Milli-Q water after pH adjustment. A 50-uL sample aliquot was directly injected with the 
mobile phase (50% aq methanol/0.1% formic acid) at a flow rate of 1 mL/min and split at 120 
uL/min to ion source. The heated capillary temperature was set at 350°C. The mass spectrum was 
obtained with a 1-min scan time, and each scan was set at 50 ms. 
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2.3.4 Confirmation of [FeIH(PAR)2]+ identity by isotope distribution analysis 
A zoom scan was performed on the LCQ Deca to record the isotope pattern of the 
[Fem(PAR)2]+ complex at m/z 484. The empirical formula of the complex 
(FeC22Hi6N604) was entered into an isotope calculator [27], which calculated the relative 
abundance of the peaks arising from the isotopes. The theoretical isotope pattern (Figure 
2.8 inset) matches that observed for the m/z 484 ion shown as a zoom scan in Figure 2.8. 
A comparison of the relative abundance of the isotope peaks in the theoretical and 
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Figure 2.8: Zoom scan of the MH+ ion of the [FeIH(PAR)2]+ complex and its theoretical mass 
spectrum (inset). The experimental conditions are given in the legend of Figure 2.7. The zoomed 
scan was performed at 50 ms/scan. 
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 Calculated using the isotopic calculator in Ref [27]. 
b
 Peak heights from zoom scan in Figure 2.8. 
2.4 Quantitative analysis of total iron 
In order to ensure the acceptability of a method for quantitative analysis, certain 
specifications need to be met. These are defined by the US FDA in their guidelines for 
industry [28, 29]. The bioanalytical method validation criteria were adopted here because 
of their relevance for the current analysis process and sample preparation procedures. The 
FDA requires that every sample determination include a calibration curve and quality 
control checks, and acknowledges that most current bioanalytical methods use mass 
spectrometry. The need for a calibration curve is because of the inherent variability in the 
processing of each sample, in extraction recovery, and from signal variation in the 
instrumentation. It should also be emphasized that the FDA guidelines are used as a 
foundation for establishing quantitative analytical methods for the determination of an 
active pharmaceutical ingredient (API). Specifications for the quantitative analysis of an 
-24-
API are usually more stringent than for pigments [28], and the figures of merit adopted 
are summarized in Table 2.6. 
Quantitative analysis was performed here using the selected-ion monitoring (SIM) 
mode of the mass spectrometer at m/z 484. In this mode, the sensitivity of detection is 
enhanced and it is also significantly more selective than full-scan mode. SIM mode is 
targeted only at the m/z value of the specific ion of interest, and ions at other m/z values 
will not be detected in the mass spectrometer. Thus, selection of SIM mode will help in 
attaining the required sensitivity and selectivity (Table 2.6). 
Table 2.6: Method validation figures of merit based on US FDA guidelines3 
Definition 
Limit of Detection (LOD) 
Limit of Quantitation (LOQ) 
Correlation coefficient (R ) 






Signal-to-Noise ratio (S/N) > 3 or 
3xStandard Deviation 
Signal-to-Noise ratio (S/N) > 10 or 
1 OxStandard Deviation 
>0.99 
± 20% at LOQ, ± 15% at level > LOQ 
± 20% at LOQ, ± 15% at level > LOQ 
Signal-to-Interference ratio > 5 
Demonstrate stability 
Meet precision and accuracy for intra-
and inter-day analyses 
Specifications are extracted from the US FDA guidelines for bioanalytical method validation 
[28] 
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2.4.1 Figures of merit using the LCQ ion trap mass spectrometer 
Standards containing 2 to 71 uM of iron were analyzed with the ion trap mass 
spectrometer. The calibration curve and regression analysis (Figure 2.9) reveal that a 
linear relationship was obtained with correlation coefficient > 0.99 when the peak 
intensity at m/z 484 was plotted versus concentration up to 43 uM iron. At higher 
concentrations, the TIC levelled off for the reason described in Chapter 3. Figure 2.9 also 
shows two lines; the blue line represents the calibration line without correction for 
background interference, the red line represents the corrected line. The offset in the two 
lines reflects a background interference in the analysis of- 6%. Following this finding, 
investigation of the sources of interference (Section 2.4.2) was performed. Use of 
appropriate labware as well as efficient cleaning protocols for the labware and 
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Figure 2.9: Total iron calibration curve using the LCQ ion trap mass spectrometer. 
50 uL of the Fe standards were directly injected with the mobile phase (50% aq methanol/0.1% 
formic acid) at a flow rate of 1 mL/min and split to 120 (xL/min to ion source. The heated 
capillary temperature set at 350°C. 
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Table 2.7 summarizes the results for the quality control (Qc) sample using the 
regression-line equation from Figure 2.9. Both precision (1.88% and 1.98% without and 
with correction) and accuracy (-5.2% and -4.6% without and with correction) meet the 
acceptance criteria according to the US FDA guidelines. However, the corrected and non-
corrected values showed a negative bias indicating that the concentrations used were 
close to the limit of the dynamic range of the instrument. This bias is also revealed in the 
negative y-intercept for the corrected curve. From standard deviation, the LOD and LOQ 
were calculated to be 2 and 8 uM Fe, respectively (Table 2.7). 
2.4.2 Interference minimization 
Following identification of the appropriate ligand for the complexation, 
optimization of the reaction conditions were further pursued. As seen in Figures 2.6A, 
2.6C, and 2.7C, the matrix blanks exhibit peaks at m/z 552 (for PAN) and m/z 484 (for 
PAR) due to trace iron impurities in the reagents (HC1, methanol, and formic acid), 
instrumentation, and labware used in the analysis. Background interference was also seen 
in the calibration curve generated using the ion trap mass spectrometer (Figure 2.9). Iron 
impurity is unavoidable, but it can be subtracted if kept constant. Thus, the same reagents 
and instrumentation were used throughout the sample preparation so that the labware 
were the main variable source of iron. The interference from the labware following 
different washing procedures was evaluated by measuring the matrix blank containing 
PAR. The washing procedures were adopted from an article by Gardner and Carey [30], 
and the total ion current was measured with the ion trap operating in SIM mode at the 
m/z value (484) of [Fem(PAR)2]+ (Figure 2.7D). 
-27 -





















































































 Target concentration of Qc sample. b Experimental results obtained using the calibration curve 
without background correction. c (Experimental-Target)/Target x 100, using the calibration 
curve without background correction. d Experimental results obtained using the calibration curve 
with background correction. e (Experimental-Target)/Target x 100, using the calibration curve 
with background correction. f %RSD = SD/Mean x 100. B LOD calculated from the standard 
deviation (SD): LOD = 3xSD. h LOQ = lOxSD 
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From the results in Table 2.8, it is obvious that use of polycarbonate-based flasks from 
Nalgene, which have been washed by the company's procedure (Section 2.2.3) and rinsed 
with HC1, produces the lowest background interference. Following this finding, 
polycarbonate-based flasks were used in all future analyses. 
Since the FTPLC system used in this thesis was not designed for elemental 
analysis, some of the plumbing consisted of metal-based tubing. Such tubing could 
contribute to trace iron interference, so critical tubing in the flow path was replaced with 
polymer-based PEEK® tubing. The stainless steel capillary tubing connecting the HPLC 
pump to the autosampler injector, the autosampler injector to the ion source of the mass 
spectrometer, and in the flow splitter was also replaced with PEEK® tubing (Figure 2.10). 
Furthermore, prior to analysis, the system was flushed with 50% aq methanol/1% 
CH3COOH, followed by 50% aq methanol. Replumbing of the triple quadrupole mass 
spectrometer was also performed to increase of the dynamic range of the calibration 
curve following analysis of the ion trap data (Section 2.4.1). The efforts made to increase 
the dynamic range of the triple quadrupole mass spectrometer are described in Chapter 3. 
-29-
Table 2.8: Trace iron impurity in the labware 
























 Total ion current (TIC) was recorded in SIM mode at m/z 484 using a LCQ ion trap mass 
spectrometer (n=l). A 50-uL sample aliquot was directly injected with the mobile phase (50% aq 
methanol/0.1% formic acid) at a flow rate of 1 mL/min and split at 120 uL/min to ion source. The 
heated capillary temperature was set at 350°C. b 50-mL Nalgene (polycarbonate) volumetric 
flasks or 50-mL glass volumetric flasks. c Flasks were washed using the company's procedure 
(Section 2.2.3) and then rinsed 3x (where indicated) with 10% acid. d New Nalgene flasks were 
used as received from the manufacturer. Note: no new glassware was purchased and all 
glassware had already been washed using the company's procedure (Section 2.2.3). 
2.4.3 Figures of merit using the triple quadrupole mass spectrometer 
To increase the sensitivity of detection as well as dynamic range of the calibration 
curve, analyses were performed on a triple quadrupole mass spectrometer. A triple 
quadrupole mass spectrometer differs from an ion trap mass spectrometer in that the 
transmission of ions occurs linearly, which enhances detection at a given m/z value and is 
expected to cover a wider dynamic range. 
When plotting the TIC peak area in SIM mode at m/z 484 vs concentration, a 
linear correlation was found from 2 uM to 43 uM total iron (Figure 2.11). Surprisingly, 
this dynamic range is similar to that obtained with ion trap mass spectrometer, and further 
investigations are described in Chapter 3. 
- 3 0 -
Figure 2.10: Instrument replumbing with PEEK tubing. Stainless steel capillary tubing (1) 
from the HPLC pump to the autosampler injector (1.5 mm OD, 0.2 mm ID), (2) from the 
autosampler injector to the ion source of the mass spectrometer (1.5 mm OD, 0.1 mm ID) and (3) 
in the flow splitter. 
Figure 2.11 also shows that the calibration lines, corrected and not corrected for 
background interference, are practically superimposable. This further indicates that the 
cleaning and plumbing procedures minimized background interference (Figure 2.11 vs 
Figure 2.9). 
The LOD (2 uM) is the same as that obtained using the ion trap instrument, but in 
this case, the LOQ is equal to LOD. Since trace iron impurity is unavoidable, it is more 
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meaningful to use a signal-to-interference ratio than a S/N. With the LOQ at 2 uM, the 
S/N calculated by Xcalibur, the instrument's software, was determined to be 100. Thus, 
technically, the LOQ could be pushed 10-fold lower to meet 10 x S/N, but this would 
result in iron over-estimation due to the background interference. With the LOQ at 2 uM, 
the signal-to-interference ratio was determined to be > 5 (Figure 2.12). This ratio meets 
FDA guidances which requires that the lowest standard concentration in the calibration 
curve (i.e., the LOQ) exhibit a response that is > 5-fold higher than that of the blank 
(Table 2.6) [29]. Figure 2.12 also shows that the method specificity criterion is met, since 
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• no background correction • with background correction 
Figure 2.11: Total iron calibration curve obtained on the triple quadrupole mass 
spectrometer. A 50-uL sample aliquot was directly injected with the mobile phase (50% aq 
acetonitrile/0.1% formic acid) at a flow rate of 1 mL/min and split at 120 (xL/min to ion source. 
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Figure 2.12: Overlay ESI MS TICs of matrix blank and LOD standard. See experimental 
details in the legend of Figure 2.11. 
Method repeatability or robustness was tested by preparing intraday and interday 
quality control (Qc) samples. Intraday Qc samples were processed on the same day as the 
calibration standards while the interday Qc samples were processed the day after the 
standards and the intraday Qc samples. The Qc samples were targeted at two levels 
within the linear range of the calibration curve, one at ~ 3x the lowest concentration and 
the other at 80% of the highest concentration. The intraday analysis involved duplicate 
Qc preparation at each concentration, whereas single replicates were prepared for the 
interday analysis. Triplicate measurements were recorded for each Qc sample and each 
calibration standard. The means of the signal from the total area of the TIC peaks at m/z 
484 were plotted against iron concentration. The ranges, which indicate the minimum and 
the maximum signal obtained from the triplicate measurements, are indicated by the y-
error bars in Figure 2.13. The results (Table 2.9) show that repeatability was established 
since all Qc values are within the accepted criteria for precision and accuracy listed in 
Table 2.6. 
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Figure 2.13 reveals that the standards were stable for at least two days when 
stored under ambient laboratory conditions. The results obtained using the 2-day 












R2 = 0.993 
y=81559x-11611 
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Figure 2.13: Calibration curves obtained using the triple quadrupole mass spectrometer on 
two consecutive days. Experimental conditions given in the legend of Figure 2.11. 
2.4.4 Tablet extraction and iron recovery 
Following method optimization and validation using the triple quadrupole mass 
spectrometer (Section 2.4.3), tablets containing iron oxide pigment were analyzed. 
Pigment was extracted from red and yellow film-coated tablets and also from compressed 
tablets containing dispersed pigments. Core tablets containing no pigment but with 
similar formulation to the tablets with pigment were also extracted. To establish its 
percent recovery, a known amount of iron standard was added to the core tablets and 
extracted in the same manner as the test tablets. 
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 Data obtained as outlined in the legend of Figure 2.11. b Qc is a quality control sample of 
known target concentration to check for accuracy. c (Observed-Target)/Target x 100. d Standard 
deviation/Mean x 100. 
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Table 2.10 compares the total iron found in the tablets with the expected amounts. 
The percent iron oxide in the pigment mixture was not revealed by the supplier so the 
pigment was assumed to contain 55% iron oxide, the maximum allowed by the FDA 
(Chapter 1). The recovery of the iron added to the core tablets was found to be 93% and 
assuming 55% iron oxide in the pigments, the recovery of iron oxide from the test tablets 
is within the specification listed in Table 2.6 (± 20%) except for the red film-coated 
tablets. It should also be emphasized that the pigment uniformity, unlike API uniformity, 
was never optimized in the tablets. In addition, different pigment was used in each tablet 
type in Table 2.10. Importantly, 93% recovery from the spiked standard indicates that the 
extraction process is efficient. 
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 Tablets extracted as described in Section 2.2.5. b Average experimental results reported from 
n=2. c Expected concentration assuming 55% iron oxide in pigment. d Observed/Expected x 100. 
e
 Film-coated tablet. f Oral compressed tablet. Experimental details are given in the legend of 
Figure 2.11. 
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2.4.5 Comparison of ICP-OES and ESI-MS results 
ICP-OES analyses were performed to confirm the applicability of the ESI-MS 
method for in-process testing of tablets containing iron oxide pigment. It should be noted 
that complexation is not required to quantitate iron by ICP-OES. The values obtained by 
ESI-MS (Table 2.10) were plotted against those obtained by ICP-OES and a good 
correlation (R2 > 0.99) was obtained (Figure 2.14). This approach for comparing two 
different methods was adopted from De and Roberts [31]. In addition, the Student's t-test 
was performed and the results are given in Table 2.11. The paired-t test value was 
determined using a calculator available on the web [32]. The threshold p-value is set at 
0.05 and a p-value greater than the threshold indicates that the difference is not 
statistically significant. Based on the correlation coefficient (0.9955) and p-value 
obtained here (0.1378), the ESI-MS and ICP-OES results are not statistically different. 
Thus, the ESI-MS method developed here is comparable in performance to ICP-OES, and 
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Figure 2.14: Comparison of total iron analysis by ESI-MS and ICP-OES. Data taken from 
Table 2.11. 
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 Results obtained by ESI-MS are from Table 2.10 taking the 5x dilution factor into account since 
working solutions for ICP-OES were 5x more concentrated than those used in ESI-MS. Samples 
for ICP-OES were aspirated into the system directly without any further additional preparation 
prior to the last dilution step when PAR was added (Section 2.2.5). b ICP-OES conditions: 
nebulizer gas was argon, sample flush time was 30 s, and the plasma was generated using RF 
power of 1150W. The nebulizer flow was 0.7 L/min and the auxiliary gas flow 0.5 L/min. The 
259.9-nm emission line was used for detection of iron. c Film-coated tablet. d Oral compressed 
tablet. 
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Chapter 3 Characterization of the iron-PAR complexes 
3.1 Introduction 
In Section 2.4.1, it was noted that the calibration curve generated using the LCQ 
ion trap mass spectrometer levelled-off at 43 uM iron (Figure 2.9). This behaviour was 
not unexpected because ion transmission from the ion trap to the detector is not linear. 
Further analysis was carried out on a triple-quadrupole mass spectrometer, which is 
expected to exhibit an increased linear range compared to the ion trap mass spectrometer. 
Using the same heated capillary temperature, spray voltage, LC mobile-phase 
composition, mobile-phase flow-rate, split ratio to the ion source, the calibration range 
increased from 43 uM on the LCQ to 86 uM on the TSQ. The LOQ remained the same, 
being ~ 2 uM. 
In addition, the Fe-PAR calibration standards exhibited a linear relationship with 
the R2 > 0.99 on both day 1 and day 2. However, the slope of calibration line decreased 
over time as shown in Figure 3.1, which suggested that the standards were unstable. At 
first thought, the levelling-off of the calibration curve at higher iron concentration and the 
decreasing slope of the calibration line with time were attributed to insufficient PAR 
despite the fact that the ligand was 35% in excess (233 uM) relative to the highest iron 
concentration (86 uM) assuming formation of the [FeHI(PAR)2]+ bis complex. As a result, 
further investigations into these issues were warranted. 
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3.2 Effects of increasing PAR concentration 
An Fem standard was prepared from the commercial stock (1000 ppm Fe1", Ricca 
Chemical Co, TX, USA) by dilution with Milli-Q water. Rather than preparing a range of 
calibration standards, the highest iron concentration (86 uM) within the dynamic range 
(Figure 3.1) was examined. A 2.23 mM PAR stock solution was prepared in 100% 
methanol and added to the 86 uM Fe"' standard in water (pH ~3). Spectra were recorded 
in a 0.2-cm cuvette over a 24-h period at different PAR concentrations (Figure 3.2). The 
sample containing 10% methanol was only monitored over a 2-h period due to the 
formation of a precipitate within 30 min. The absorbance at 530 nm, which is the visible 







I Linear (no correction - Day 1) Linear (with correction - Day 1) Linear (Day 2) Linear (Day 6) I 
Figure 3.1: Iron calibration plots using the triple quadrupole mass spectrometer over a 
period of 6 days with 233 jiM PAR. A 50-uL aliquot of each standard was directly injected 
with the mobile phase (50% aq methanol/0.1% formic acid) at a flow rate of 1 mL/min and split 
at 120 uL/min to ion source. The heated capillary temperature was set at 350°C. The iron 
standards were prepared from the commercial stock solution as described in Section 2.2.4. 
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Figure 3.2: Changes in the UV-Vis spectra of iron-PAR solutions over time vs PAR 
concentration. Spectra were recorded in a 0.2-cm cuvette. The aqueous solutions contained 86 
uM Fem standard and the following PAR and methanol concentrations: (A) 223 uM PAR and 
10% methanol; (B) 223 uM PAR and 40% methanol; (C) 446 uM PAR and 20% methanol; (D) 
669 uM PAR and 30% methanol; (E) Same as (D) but zoomed lOx from 400 nm to 600 nm; (F) 
892 uM PAR and 40% methanol; (G) Same as (F) but zoomed lOx from 400 nm to 600 nm. 
From the results in Table 3.1, it appears that a minimum of 40% methanol is required 
to prevent precipitation in the iron/PAR solution. Also, regardless of the amount of 
excess PAR in the solution, the 530-nm absorbance decreases over 30 min (10% 
methanol) to 24 h (Table 3.1). The composition of the precipitates was not investigated, 
- 4 1 -
but it is suspected that the free PAR ligand has low solubility in a highly aqueous 
environment at the pH of the experiment (~3). The PAR used in this experiment was in 
the free base form, rather than the salt form that is commonly used in the literature for 
colorimetric analysis [33-35]. The structure of the free acid (protonated form) is shown in 
Table 2.4. The salt form is highly soluble in water, whereas the free base form is soluble 
in organic media [21]. Nevertheless, with 40% methanol content in the sample solution, 
insufficient ligand was not the cause of the issues discussed in Section 3.1. 








































 Solutions of 86 uM Fe standard containing the PAR and methanol concentrations indicated 
were prepared at room temperature. Spectra were recorded in a 0.2-cm cuvette. b Percent excess 
was calculated based on two mole equivalents of PAR for each mole [Fe]. 
3.3 Effects of organic solvent on stability of iron-PAR complexes 
PAR was dissolved in 100% methanol or 100% acetonitrile and added to 86 uM 
of Fe111 standard or Fe11 in water at pH ~3. The latter was prepared using FeSCU as source 
of ferrous iron, and the total organic content of the sample solutions was adjusted to 40%. 
Evaluation of sample stability was performed visually by comparing the color of the 
solution over a one-week period, and a summary of the findings is given Table 3.2. 
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 Solutions containing 86 uM Fe or 86 uM FeS04 standard with 233 uM PAR in the solvent 
indicated were left standing at ambient laboratory conditions, and the color was visually observed 
over time. b * indicates that no precipitate was observed and S indicates that a precipitate was 
observed. 
The initial color of the Fe111 and Fe11 complexes in 40% acetonitrile did not change over a 
period of one week, while in 40% methanol the color changed from ruby red to red-
brown (Table 3.2). Formation of a red-brown color suggested possible Fe111 reduction in 
methanol. Thus, an HPLC method was developed using a diode-array detector to separate 
the Fe111 and Fe11 PAR complexes before their introduction into the ESI source of the mass 
spectrometer. Separation of the [Feni(PAR)2]+ and [Fen(PAR)2] complexes and their 
relative retention times on the HPLC column can be seen in Figure 3.3. An overlay of the 
spectra recorded on the diode-array detector reveals that the Fe" and Fe111 complexes have 
isosbestic points at 396 nm and 505 nm (Figure 3.4). Table 3.2 shows that the formation 
of[Fen(PAR)2] was slower in acetonitrile. Thus, this solvent was used to replace 
methanol in further analyses. 


















3.0 3.5 4.0 4.5 
Figure 3.3: Overlay of HPLC-Vis (530 nm) chromatograms of solutions of PAR, 
[Fem(PAR)2]+, and [Fe"(PAR)2]. A 5-uL aliquot of a freshly prepared solution in 40% aq 
acetonitrile of (a) 223 pM PAR, (b) 86 uM FeS04 with 223 uM PAR, (c) 86 uM Fe1" standard 
with 223 uM PAR was injected onto an Agilent Technologies, Eclipse Plus CI8 RRHT column 
(50 x 4.6 mm, 1.8 ^m particle size at 40°C). The mobile phase (30% aq 0.05% TFA in 
acetonitrile) was pumped at a flow rate of 1 mL/min through HPLC system equipped with a 
diode-array detector set at 530 nm. The total run time was 5 min. 
[Fe"(PAR)2] 
300 400 500 600 
Wavelength (nm) 
700 800 
Figure 3.4: Overlay of UV-Vis Spectra of PAR, [Fein(PAR)2]+ and [Fe"(PAR)2] complexes. 
Spectra were recorded using the diode-array detector during the HPLC analysis described in 
Figure 3.3. The Fe" and Fem complexes exhibit isosbestic points at 404 nm and 505 nm (dashed 
lines). 
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3.4 Reduction of Fe upon addition of PAR 
Representative HPLC chromatograms of standards containing 223 uM PAR and 
57 uM or 86 uM Fe111 standard in 40% aq acetonitrile are shown in Figure 3.5. The eluate 
was monitored at 400 nm, which is close to the isosbestic point of the Fe11 and Fe111 
complexes (Figure 3.4) and it is also the highest UV wavelength absorption setting 
available using the variable-wavelength detector. Free PAR was well resolved from its 
complexes (Figure 3.5); hence, its absorbance at 400 nm (Figure 3.4) did not interfere. 
The calibration curve shown in Figure 3.6 reveals that a plot of [Fem(PAR)2]+ vs 
peak area at 400 nm is not linear suggesting that [Fen(PAR)2] was present in each 
calibration standard. The sum of [Fem(PAR)2]+ and [Fen(PAR)2] peak areas vs total iron 
") Til 
concentration was linear (R = 0.9999) confirming that Fe was partially reduced when 
PAR was added since the standards were assayed within 1 h of their preparation. In 
addition, Figure 3.6 reveals that no Fe111 complex was formed at low iron concentration 
(up to ~ 30 |j.M) suggesting that Fem is reduced to Fe11 by excess PAR. Products formed 
on PAR oxidation were not investigated. Yotsuyanagi et al. [23] reported that 
[Fen(PAR)2] is more stable than [Fem(PAR)2]+ as is also the case for the Phen complexes. 
Interestingly, they also found that the [Com(PAR)2]+ was more stable than the 
[CoI1[(PAR)2] complex. Oxidation of [Con(PAR)2] and reduction of [Fem(PAR)2]+ was 
suspected when solutions of these complexes were introduced from a capillary 
electrophoresis system into the ESI source of a LCQ-Duo mass spectrometer [36]. 
The order of addition of reagents, buffering at pH 4, 5, 7, and adding an oxidant 
(H2O2) were investigated to establish their effects on [Feni(PAR)2]+ reduction. Jezorek et 
al. [37] indicated that PAR is light sensitive, so the sample solution was protected from 
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light during preparation. These modifications did not prevent the reduction of the 
[Feni(PAR)2]+ complex. 
Iron 57 \iM 
Iron 86 pM 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 
Time (min) 
Figure 3.5: HPLC-UV (400 nm) chromatograms of the standard solutions. A 50-uL aliquot 
of 57 and 86 uM Fem standard with 223 uM PAR in 40% aq acetonitrile was injected onto an 
Agilent Technologies, Eclipse Plus C18 RRHT column (50 x 4.6 mm, 1.8 um particle size at 
40°C). The mobile phase (50% aq 0.02% acetic acid/0.01% TFA in acetonitrile) was pumped at a 
flow rate of 0.6 mL/min through the HPLC system equipped with a variable-wavelength detector 
set at 400 nm. The total run time was 3 min. 
100 
y = 0.9026X + 0 .5883 
R2 = 0.9999^. 
0 10 20 
• Felll • Fell » Total iron 
Figure 3.6: HPLC-UV (400 nm) calibration curves for [FeHI(PAR)2]+, [Fe"(PAR)2], and total 
iron. Experimental conditions are given in the legend of Figure 3.5. Calibration standards were 
assayed 1 h after preparation. 
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3.5 Addition of reductant 
Since the [Fen(PAR)2] complex is stable, a reductant was added to fully reduce 
the complex. Two commonly used reductants are hydroxylamine and ascorbic acid, and 
their relative efficiencies were monitored by HPLC (Figure 3.7). A trace amount of 
[Fem(PAR)2]+ was detected in the hydroxylamine solution but not in the ascorbic acid 
solution. Thus, ascorbic acid was selected as the reductant in further analyses. Ascorbic 
acid acts as a two-electron reductant as shown in equation 3.1 [24, 25]; thus, two moles 
of Fem are reduced by one mole of the acid (equation 3.2). 
[Fe" (PAR) 2 ] 
( A ) 
1 
14 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2 
Time (min) 
[Fe" (PAR) 2 ] 
1.13" 
( B ) 
1 
i I i i i i i M i r i i i i 
0.6 0.8 1.0 1.2 1.4 1.6 1.8 2 
Time (min) 
Figure 3.7: HPLC-UV (400 nm) analysis of [Fein(PAR)2]+ reduction by (A) 345 uM 
hydroxylamine and (B) 136 uM ascorbic acid. A 50-uL aliquot of 86 uM Fem standard with 
223 uM PAR in 40% aq acetonitrile was injected onto an Agilent Technologies, Eclipse Plus CI8 
RRHT column (50 x 4.6 mm, 1.8 urn particle size at 40°C). The mobile phase (50% aq 0.02% 
acetic acid/0.01% TFA in acetonitrile) was pumped at a flow rate of 0.6 mL/min through the 




ascorbic acid (aa) 
+ 2H+ + 2e-
dehydroascorbic acid (dhaa) 
3.1 
aa + 2[Fe'"(PAR)2]+ dhaa + 2[Fe"(PAR)2] + 2H+ 3.2 
The ESI mass spectrum of the ascorbate-reduced [Fen(PAR)2] complex was 
recorded and is shown in Figure 3.8. The base peak at m/z 485 corresponds to the 
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Figure 3 8: ESI mass spectrum of the ascorbate-reduced [Fen(PAR)2] complex. A 50-uL 
aliquot of 86 uM Fe111 standard with 223 uM PAR and 136 uM ascorbic acid in 40% aq 
acetonitrile was directly injected with the mobile phase (50% aq acetonitrile/0.1% formic acid) at 
a flow rate of 1 mL/min and split at 120 uL/min to ion source. The heated capillary temperature 
was set at 350°C. 
When a solution of [Fem(PAR)2]+ in 40% aq methanol was re-examined by LC-MS in 
56i- 11/ SIM mode (m/z 485) after one week, peaks due to both [30Fe"(PAR)2+H] and 
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[57Fem(PAR)2]+ were observed (Figure 3.9). This clearly indicates that these isobaric 
species are resolved on the HPLC column using the optimized conditions given in the 
legend of Figure 3.9. 
[56Fe"(PAR)2+H]+ 
1.0 1.2 1.4 
Time (min) 
Figure 3.9: LC-MS TIC chromatogram in SIM mode at m/z 485 of a [Fem(PAR)2]+ solution 
after one week. A 10- uL aliquot of 86 uM FenI standard with 223 uM PAR in 40% aq methanol 
was injected onto an Agilent Technologies, Eclipse Plus C18 RRHT column (50 x 4.6 mm, 1.8 
urn particle size at ambient column temperature). The mobile phase (40% aq 0.02% acetic 
acid/0.01% TFA in acetonitrile) was pumped at a flow rate of 1 mL/min through the HPLC 
system and split at 120 uL/min to ion source. The heated capillary temperature was set at 350°C. 
The total run time was 2.4 min. 
The stability of the [Fen(PAR)2] complex was examined using the 86 uM Fem 
standard with the reductant (ascorbic acid) at different pH values (1.5, 4, 8, and 10). To 
ensure a final solution pH of 1.5, a 0.1-N H O (with a measured pH of 1.55) was used for 
dilution instead of Milli-Q water. The sample of 86 uM [Fen(PAR)2] in 40% aq 
acetonitrile with 0.1 N HC1 (pH 1.5) was found to be stable for at least 1 day. Calibration 
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standards at pH 1.5 were assayed by LC-MS in SIM mode at m/z 485. The results shown 
in Figure 3.10 reveal that the points do not yield a straight line. A variable wavelength 
detector was also coupled to the HPLC, and the plot of the peak height of the 
[Fen(PAR)2] absorbance at 400 nm vs iron concentration (Figure 3.11) was similar to that 
in Figure 3.10. Thus, the nonlinearity is not due to ion suppression in the ESI source. 
Examining the pKa values of PAR (Table 2.4) indicates that at pH 1.5 two coordination 
sites of PAR are protonated, the pyridine nitrogen and the ortho hydroxyl. It was, 
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Figure 3.10: LC-MS standard curve of TIC at m/z 485 vs [Fe"(PAR)2] concentration. A 10-
uL aliquot of Fem standard with 223 uM PAR and 136 uM ascorbic acid in 40% aq 
acetonitrile/0.1 N HC1 was injected onto an Agilent Technologies, Eclipse Plus CI8 RRHT 
column (50 x 4.6 mm, 1.8 um particle size at ambient column temperature). The mobile phase 
(40% aq 0.02% acetic acid/0.01% TFA in acetonitrile) was pumped at a flow rate of 1 mL/min 
and split at 120 uL/min to ion source through the HPLC system equipped with a variable-
wavelength detector set at 400 nm. The heated capillary temperature was set at 350°C. The total 
run time was 2.4 min. 
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Figure 3.11: HPLC-UV (400 nm) calibration curve of standards from Figure 3.10. 
[Fe"(PAR)2] standards prepared in water (measured pH ~3) with 70% acetonitrile 
were found to be stable for at least 1 day. Consequently, [Fen(PAR)2] calibration samples 
prepared in 70% aq acetonitrile at pH 3 were injected into the LC-MS. The calibration 
curve in SIM mode at m/z 485 was not a straight line (Figure 3.12 A) but a plot of peak 
height at 400 nm vs iron concentration exhibited good linearity with a high degree of 
correlation (Figure 3.12B). This suggests that there is an inherent problem with the MS 
method and not with the sample solutions. Thus, conditions suitable for MS analysis were 
researched. 
Sample pH and mobile phase pH were varied to examine the effects on the 
standard curve. The sample pH was increased from pH ~ 3 to 5 by buffering with 20 mM 
ammonium acetate in order to deprotonate PAR and hence promote stronger 
complexation. The mobile phase pH was also increased to 4.5 from 3.3 to avoid pH 
mismatch. Unlike the evaluations in Sections 3.2 to 3.3, which utilized a single standard 
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solution (86 uM iron), three calibration points were plotted for each evaluation as shown 
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Figure 3.12: LC-MS and HPLC-UV (400 nm) [Fe"(PAR)2] calibration curves in 70% aq 
acetonitrile. Peak heights vs iron concentration of (A) TIC in SIM mode at m/z 485 and (B) 
HPLC-UV absorbance at 400 nm. A 10-uL aliquot of Fem standard with 223 uM PAR and 136 
uM ascorbic acid in 70% aq acetonitrile was injected onto an Agilent Technologies, Eclipse Plus 
C18 PvRHT column (50 x 4.6 mm, 1.8 um particle size at ambient column temperature). The 
mobile phase (40% aq 0.02% acetic acid/0.01% TFA in acetonitrile) was pumped at a flow rate of 
1 mL/min and split at 120 uL/min to ion source through the HPLC system equipped with a 
variable-wavelength detector set at 400 nm. The heated capillary temperature was set at 350°C. 
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Figure 3.13: LC-MS [Fe"(PAR)2] calibration curves vs pH. Peak heights of TIC in SIM 
mode at m/z 485 were measured. A 10-uL aliquot of 6 uM, 29 uM, and 86 uM Fein standard 
with 223 uM PAR and 136 uM ascorbic acid in 40% aq acetonitrile was injected onto an Agilent 
Technologies, Eclipse Plus C18 R.RHT column (50 x 4.6 mm, 1.8 urn particle size at ambient 
column temperature). The mobile phase (40% aq 0.02% acetic acid/0.01% TFA in acetonitrile) 
was pumped at a flow rate of 1 mL/min and split at 120 uL/min to ion source through the HPLC 
system equipped with a variable-wavelength detector set at 400 nm. The heated capillary 
temperature was set at 350°C. The total run time was 2.4 min. 
Direct infusion of the samples solution into the mass spectrometer at a flow rate 
of 10 uL/min with a 250-uL Hamilton syringe was performed but this did not produce a 
straight line either (Figure 3.14), suggesting that PAR complexation with Fe11 may not be 
suitable for quantitative analysis by ESI-MS. 
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Figure 3.14: ESI-MS [Fe"(PAR)2] calibration curve. Following direct infusion of the 
standards into the mass spectrometer, peak heights in SIM mode at m/z 485 were measured. 
Solutions containing Fem standard and 223 uM PAR and 136 uM ascorbic acid in 40% aq 
acetonitrile were directly infused using a 250-uL Hamilton syringe at a flow rate of 10 uL/min. 
The scan time was 1 min and the heated capillary temperature was set at 350°C. 
The [Fe (Phenb] complex was reinvestigated since Phen forms stable complex 
with Fe" [39]. In Section 2.3.1, it was concluded that the [Fen(Phen)3]2+ complex is 
thermally labile at temperatures greater than 150°C. However, evaluation of the 
[Fen(Phen)3]2+ solutions in SIM mode at m/z 298 at 150°C also did not yield a good 
linear correlation (Figure 3.15). In addition, lowering the transfer capillary temperature to 
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Figure 3.15: ESI-MS [FeI!(Phen)3]2+ calibration curve. Following direct infusion of the 
standards into the mass spectrometer, peak heights in SIM mode at m/z 298 were measured. 
Solutions containing Fem standard and 404 uM Phen and 136 uM ascorbic acid in 40% aq 
methanol were directly infused using a 250-uL Hamilton syringe at a flow rate of 10 uL/min. The 
scan time was 1 min and the heated capillary temperature was set at 150°C. 
Decreasing the calibration range to 43 uM [Fen(PAR)2] did not yield a straight 
line (Figure 3.16A). However, the response from the variable wavelength detector at 400 
nm revealed good linear correlation as shown in Figure 3.16B. This calibration equation 
was used to check the Qc samples, and the results (Table 3.3) were within the precision 
( 1 - 3 %RSD) and accuracy (-1% to + 7%) criteria required by the US FDA guidelines 
(Table 2.6). 
Efforts to establish a linear calibration curve for the [Fen(PAR)2] complex did not 
succeed using MS detection. Presumably, the protonated [Fe"(PAR)2+H]+ complex is not 
quantitatively formed in the ESI source. Despite the fact that ESI-MS is a sensitive and 
selective technique, many processes can occur during electrospray formation, such as 
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adduct formation, gas-phase ion reactions, and un-predictable ionization, all of which can 
lead to non-linear responses [16]. As a result of the nonlinear regression, MS quantitation 
of [Fen(PAR)2+H]+ in the SIM mode at m/z 485 is not feasible using an ESI source with 
a heated transfer capillary. However, quantitation by HPLC-UV/Vis would be possible 
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Figure 3.16: LC-MS and HPLC-UV (400 nm) [Fe"(PAR)2] calibration curves up to 43 uM 
iron. Peak heights vs iron concentration of (A) TIC in SIM mode at m/z 485 and (B) HPLC-UV 
absorbance at 400 nm. A 10-uL aliquot of Fem standard with 223 uM PAR and 136 uM ascorbic 
acid in 40% aq acetonitrile was injected onto an Agilent Technologies, Eclipse Plus C18 RRHT 
column (50 x 4.6 mm, 1.8 um particle size at ambient column temperature). The mobile phase 
(40% aq 0.02% acetic acid/0.01% TFA in acetonitrile) was pumped at a flow rate of 1 mL/min 
and split at 120 uL/min to ion source through the HPLC system equipped with a variable-
wavelength detector set at 400 nm. The heated capillary temperature was set at 350°C. The total 
run time was 2.4 min. 
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Table 3.3: Figures of merit for iron analysis as [Fe"(PAR)2] using HPLC-UV detection at 
400 nma 








































 Experimental details are provided in the legend of Figure 3.16. b Target concentration of Qc 
sample. c Experimental results calculated using the calibration curve from Figure 3.16B. d 
(Experimental-Target)/Target x 100. e %RSD = Standard deviation/Mean x 100. 
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Chapter 4 General conclusions and suggestions for future work 
This thesis has demonstrated metal ion analysis, such as the analysis of total iron 
described in Chapter 2, is one of many capabilities of ESI-MS. Despite an extensive 
literature on ESI-MS, only one publication was found that deals directly with quantitative 
metal-ion analysis using an ESI source [36]. ESI-MS has been shown here to be 
applicable to the analysis of total iron in pharmaceutical tablets containing iron oxide 
pigment. Since the method was developed for pharmaceutical applications, method 
validation figures of merit from an industry regulator, the US FDA, were followed and 
met (Section 2.4.3, Table 2.9). 
Statistical analysis of the results obtained using ESI-MS and an instrument 
dedicated to metal-ion quantitation, ICP-OES, revealed no significant difference between 
the two methods, thus confirming the applicability of the ESI-MS in metal quantitation. 
The aim of the present study was not to replace elemental analysis performed with 
specialized and dedicated instruments such as ICP-MS/OES or AAS, but to provide an 
alternative to laboratories that require some metal-ion quantitation but do not have access 
to dedicated instruments for elemental analysis. 
Karpinska and Kulikowska [7] increased the sensitivity of [Fen(PAR)2] detection 
to 0.14 uM using colorimetric analysis. This was accomplished by the transformation of 
the observed spectra into second-order derivatives, to decrease interference from other 
metal ions. Kolomiets et al. [6] established a linear range in colorimetric analysis from 
1.43 uM to 10 uM [Fein(PAR)2]+ also using the second-order derivative of the 
absorbance. Yotsuyanagi et al. [23] achieved the same sensitivity as Karpinska and 
Kulikowska [7] by using EDTA to mask the interference, thus increasing the complexity 
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of the sample preparation. The dynamic range of the calibration curve established using 
colorimetric analysis by Vinogradov et al. [38] extended to 18 uM [Fen(PAR)2]. The 
ESI-MS method developed here yields a LOD of 2 uM for [Fein(PAR)2]+, comparable to 
that achieved by Kolomiets et al. [6], without using masking reagents or raw-data 
transformation. ESI-MS is more specific than most colorimetric methods of iron analysis 
and in addition it is linear up to 43 uM for [Fem(PAR)2]+ (Figure 2.11). Furthermore, 
ESI-MS instrumentation is found in most pharma laboratories but a limitation of the 
instruments used here was the presence of the heated capillary. 
As found in Chapter 3, a nonlinear response to [Fen(PAR)2+H]+ was observed 
using SIM mode at m/z 485. This may be due to the many variables associated with 
electrospraying a neutral complex molecule [16]. In addition, the use of excess ascorbic 
acid to reduce Fem to generate [Fen(PAR)2+H]+ could actually suppress the ionization, 
and yield the nonlinear response observed here. Despite this fact, the benefit of ESI-MS 
outweighs its limitation as shown in Chapter 2. Electrospraying of the pre-ionized 
[Fem(PAR)2]+ complex in 50% aq acetonitrile/0.1% formic acid, with the heated capillary 
temperature set at 350°C, yields a linear response over the range 2 - 4 3 uM total iron 
(Figure 2.11) in SIM mode at m/z 484. All method validation figures of merit were 
successfully met. Thus, the method can be applied in the analysis of total iron in 
pharmaceutical products containing iron oxide pigment. 
Suggested future work is to investigate the mechanism by which PAR reduces 
Fem . The question also arises if PAR reduces or oxidizes other metal ions. The reduction 
of FeHI observed in this thesis was implied by other researchers [23, 36], but no 




2. Piechocki J.T, Thoma K, Pharmaceutical Photostability and Stabilization 
Technology. 2006: CRC Press. 445. 
3. Nyamweya N, Hoag S. W, Mehta K. A, Film coating with aqueous latex 
dispersions: general considerations for formulating with pigments, in 
Pharmaceutical Technology. 2001, 8-12, 26. 
4. U.S. Department of Health & Human Services, USFDA, Summary of Color 
Additives Listed for Use in the United States in Foods, Drugs, Cosmetics, and 
Medical Devices. 2004. 
5. Kemsley J, Improving metal detection in drugs, in C&ENNews. 2008, 32-34. 
6. Kolomiets L.L, Pilipenko L. A, Zhmud I. M, Panfilova I. P, Application of 
derivative spectrophotometry to the selective determination of nickel, cobalt, 
copper, and iron(III) with 4-(2-pyridylazo) resorcinol in binary mixtures. J. Anal. 
Chem. 1999, 54(1), 28-30. 
7. Karpinska J. Kulikowska M, Simultaneous determination ofzinc(II), 
manganese(II) andiron(II) in pharmaceutical preparations. J. Pharm. Biomed. 
Anal. 2002, 29(1), 153-158. 
8. Ming X.Y, Wu Y. H, Schwedt G, HPLC analysis ofV, Co, Fe, andNi by 4-(2-
- pyridylazo)resorcinol, PAR and H2O2 and studies on complex properties 
influencing retention. Fresenius J. Anal. Chem. 1992, 342(7), 556-559. 
- 6 0 -
9. Atanassova A., Lam R, Zamble D. B, A high-performance liquid chromatography 
method for determining transition metal content in proteins. Anal. Biochem. 2004, 
335(1), 103-111. 
10. Uluozlu O.D, Tuzen M, Mendil D, Soylak M, Trace metal content in nine species 
of fish from the Black and Aegean Seas, Turkey. Food Chem. 2007, 104(2), 835-
840. 
11. Omode P.E, Ademukola S. A, Determination of Trace Metals in Southern 
Nigerian Honey by use of Atomic Absorption Spectroscopy. Spect. Letters. 2008, 
41(7), 328-331. 
12. Kokot Z.J, Matysiak J, Inductively coupled plasma mass spectrometry 
determination of metals in honeybee venom. J. Pharm. Biomed. Anal. 2008, 48(3), 
955-959. 
13. Rattner B.A, Golden N. H, Toschik P. C, McGowan P. C, Custer T. W, 
Concentrations of Metals in Blood and Feathers of Nestling Ospreys (Pandion 
haliaetus) in Chesapeake and Delaware Bays. Arc. Environ. Contam. Tox. 2008, 
54(1), 114-122. 
14. Matsumoto K, Matsunami A, Oyama H, Detection of Metal Oxides by 
MALDI/TOFMS. J. Mass Spectrom. Soc. Jpn. 2004, 52(6), 325-327. 
15. Siuzdak G, The Expanding Role of Mass Spectrometry in Biotechnology. 2003, 
MCC Press, 272. 
16. DiMarco V.B, Bombi G. G, Electrospray Mass Spectrometry (ESI-MS) in the 
Study of Metal-Ligand Solution Equilibria. Mass Spectrom. Rev. 2006, 25(3), 
347-379. 
-61 -
17. Lobinski R, Schaumloffel D, Szpunar J, Mass Spectrometry in Bioinorganic 
Analytical Chemistry. Mass Spectrom. Rev. 2006, 25(2), 255-289. 
18. Yamashita M. Fenn J. B, Electrospray ion source. Another variation on the free-
jet theme. The J. of Phys. Chem. 1984, 88(20), 4451-4459. 
19. Kenkel J, Analytical Chemistry for Technicians. 2003, CRC Press, 554. 
20. Koch S, Ackermann G, The iron(III)/l,10-phenanthroline complex as a reagent 
for the determination of some anions and organic compounds. Talanta. 1992, 
39(6), 687-691. 
21. Holzbecher Z, Divis L, Krai M, Sucha L, Vlacil F, Handbook of Organic 
Reagents in Inorganic Analysis. 1976, Ellis Horwood Ltd. 
22. Arya S.P, Mahajan M, Jain P, Spectrophotometric determination of vitamin C 
using Fe(II)-l-(2-pyridylazo)-2-naphthol complex. Indian J. Chem. 1999, 38(A), 
1303-1306. 
23. Yotsuyanagi T, Yamashita R, Aomura K, Highly selective and sensitive 
spectrophotometric determination ofiron(II) and cobalt(II) with 4-(2-
pyridylazo)resorcinol (PAR). Anal. Chem. 1972, 44(6), 1091 -1093. 
24. Harris D.C, Quantitative Chemical Analysis. 1982, W. H. Freeman and Co., 374. 
25. Ghasemi J, Seifi S, Sharifi M, Ghorbani R, Amini A, Simultaneous kinetic 
spectrophotometric determination of ascorbic acid and L-cysteine by H-Point 
standard addition method. Microchimica Acta. 2004, 148(3-4), 259-265. 
26. Keki S, Nagy L, Torok J, Deak G, Zsuga M, A simple method for estimating 
activation energies using the fragmentation yield: collision-induced dissociation 
- 6 2 -
of iron(II)-phenanthroline complexes in an electrosypray ionization mass 
spectrometer. J, Am. Soc. Mass Spectrom. 2006,17(7), 962-966. 
27. http://www2.sisweb.com/mstools/isotope.htm. 
28. http://www.fda.gov/cder/guidance/2396dft.htm, Analytical Procedures and 
Methods Validation: Chemistry, Manufacturing and Controls Documentation. 
2000. 
29. http://www.fda.gov/cder/guidance/4252fnl.htm, Guidance for Industry: 
Bioanalytical Method Validation. 2001. 
30. Gardner C.B, Carey A. E, Trace metal & major ion inputs into the Olentangy 
River from an urban storm sewer. Environ. Sci. Tech. 2004, 38(20), 5319-5326. 
31. De B.K, Roberts W. L, Performance characteristics of the Dimension RxL iron 
and total iron-binding capacity methods. Clin. Chimica Acta. 2003, 333(1), 51-57. 
32. http://www.graphpad.com/quickcalcs/ttestl xfm, Student t-test calculator, Prism. 
33. Gupta N, Nigam P. C, Kinetics and mechanism of the reaction between bis 4-(2-
pyridylazo)resorcinolferrate(III) complex and cyanide ion. Trans. Metal Chem. 
1988,13(5), 367-370. 
34. Arya S. P, Mahajan M, Jain. P, Spectrophotometric determination of Vitamin C 
with iron(II)-4-(2-pyridylazo)resorcinol complex. Anal. Chimica Acta. 2001, 
427(2), 245-251. 
35. Gavazov K, Simeonova Z, Alexandrov A, Extraction spectrophotometric 
determination of vanadium in natural waters and aluminium alloys using 
pyridylazo resorcinol (PAR) and iodo-nitro-tetrazolium chloride (INT). Talanta. 
2000, 52(3), 539-544. 
- 6 3 -
36. Cucinotta V, Carusso R, Giuffrida A, Messina M, Maccarrone G, Torrisi A, 
Separation and quantitation of metal ions by 4-(2-pyridylazo)resorcinol 
complexation in capillary electrophoresis-electrospray ionization mass 
spectrometry. J. Chromatography A. 2008, 1179(1), 17-23. 
37. Jezorek J.R, Freiser H, 4-(Pyridylazo)resorcinol-based continuous detection 
system for trace levels of metal ions. Anal. Chem. 1979, 51(3), 373-376. 
38. Vinogradov S.N, Kosinski T. F, Zak B, Complexometric determination of iron in 
heme proteins with 4-(2-pyridylazo) resorcinol. Anal. Biochem. 1982, 120(1), 
111-112. 
39 Adhikamsetty R. K, Gollapalli N. R, Jonnalagadda S. B, Complexation kinetics of 
Fe + with 1,10-Phenanthroline forming ferroin in acidic solutions. Int. J. Chem. 
Kin. 2008,40(8), 515-523. 
- 6 4 -
